Aptiv Solutions grew out of a first-hand recognition of the pressures and challenges facing drug and medical device developers – and the belief that a more dynamic paradigm for development is long overdue. Simply put, companies that continue to rely on conventional techniques risk missing out on rewarding opportunities.
So we’re focused on harnessing the power of adaptive clinical trials. To that end, we’ve combined the advanced capabilities and knowledge of subject-matter experts with the broad capabilities, deep process knowledge and flexibility of traditional CROs.
As a global company, we provide an extensive portfolio of innovative services, currently delivered by a worldwide team of more than 850 professionals. And since we don’t believe in standing still, we will evolve and adapt as we recognize obstacles and uncover opportunities – so that we can continue to help our clients succeed in whatever new development and regulatory landscape emerges in the years ahead.
Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Protein Protects Against Flu in Mice The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.